Schizophrenia Treatment Adherence Investigation (STAI)

Treatment review and feedback program to determine risk of poor medication adherence in patients with schizophrenia or schizoaffective disorder.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12607000250437

Acronym

STAI

Enrollment

550

Registered

2007-05-10

Start date

2007-07-26

Completion date

2008-09-01

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This treatment review aims to determine the risk of medication non-adherence in patients diagnosed with schizophrenia. Further, it aims to identify the proportion of patients receiving medical treatment that is inconsistent with their medication adherence risk status, assess the rate of modification of medication after the subject's adherence risk status is known, and to relate to the adherence risk status to their rate of sudden worsening of schizophrenia.

Interventions

This treatment review is designed to assess medication adherence in subjects with schizophrenia or schizoaffective disorder. Subjects will not be given any interventional treatments as part of this review. The duration of participant observation for this treatment review is 12 months.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Clinical diagnosis of Schizophrenia or Schizoaffective Disorder according to DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition). Currently treated in an outpatient clinic. Over 18 years and able to provide informed consent.

Exclusion criteria

There is no exclusion criteria for this treatment review.

Outcome results